Your browser doesn't support javascript.
loading
Radiomics-based prediction of response to immune checkpoint inhibitor treatment for solid cancers using computed tomography: a real-world study of two centers.
Yu, Yang; Bai, Yuping; Zheng, Peng; Wang, Na; Deng, Xiaobo; Ma, Huanhuan; Yu, Rong; Ma, Chenhui; Liu, Peng; Xie, Yijing; Wang, Chen; Chen, Hao.
Afiliación
  • Yu Y; The Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China.
  • Bai Y; The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, China.
  • Zheng P; The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, China.
  • Wang N; Department of MR, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China.
  • Deng X; The Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China.
  • Ma H; The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, China.
  • Yu R; The Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China.
  • Ma C; The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, China.
  • Liu P; The Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China.
  • Xie Y; The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, China.
  • Wang C; The Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, Gansu, China.
  • Chen H; The Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, Gansu, China.
BMC Cancer ; 22(1): 1241, 2022 Nov 30.
Article en En | MEDLINE | ID: mdl-36451109
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China